These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1361179)

  • 21. Alternative approaches for the induction of transplantation tolerance.
    Wood KJ
    Immunol Lett; 1991 Jul; 29(1-2):133-7. PubMed ID: 1916911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological effects of heterologous antilymphocyte serum.
    Taub TN
    Prog Allergy; 1970; 14():208-58. PubMed ID: 4404047
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunosuppression with monoclonal antibodies.
    Friend PJ
    Curr Opin Immunol; 1989-1990; 2(6):859-63. PubMed ID: 2486565
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of autoimmune diseases and graft rejection with anti-CD4 antibodies].
    Emmrich F; Burmester G; Horneff G; Emmrich J; Reinke P; Hiepe F; Kalden J; Schulze-Koops H; Volk HD
    Z Gesamte Inn Med; 1992 Nov; 47(11):500-7. PubMed ID: 1361089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of spontaneous autoimmune thyroiditis in the obese strain (OS) chickens by treatment with a monoclonal anti-CD4 antibody.
    Cihak J; Hoffmann-Fezer G; Wasl M; Merkle H; Kaspers B; Hála K; Plachý J; Wick G
    Zentralbl Veterinarmed A; 1996 Jun; 43(4):211-6. PubMed ID: 8767730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract]   [Full Text] [Related]  

  • 27. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunointervention in psoriasis with anti-CD4 antibodies.
    Thivolet J; Nicolas JF
    Int J Dermatol; 1994 May; 33(5):327-32. PubMed ID: 7913701
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
    Song HK; Alters SE; Fathman CG
    Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of IL-4 does not prevent tolerance induction in an allogeneic rat kidney transplantation model.
    Ritter T; Seifert M; Risch K; Fretz A; Tanzmann H; Brock J; Volk HD; Lehmann M
    Transplant Proc; 1999; 31(1-2):887-8. PubMed ID: 10083389
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Immunol Today; 1993 Jun; 14(6):322-6. PubMed ID: 8104411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
    Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
    Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric monoclonal CD4 antibody--a novel immunosuppressant for clinical heart transplantation.
    Meiser BM; Reiter C; Reichenspurner H; Uberfuhr P; Kreuzer E; Rieber EP; Riethmüller G; Reichart B
    Transplantation; 1994 Aug; 58(4):419-23. PubMed ID: 7915442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
    van de Linde P; Vd Boog PJ; Tysma OM; Elliott JF; Roelen DL; Claas FH; de Fijter JW; Roep BO
    Clin Exp Immunol; 2007 Jul; 149(1):56-62. PubMed ID: 17459076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-induced tolerance to organ allografts.
    Morris PJ; Wood KJ; Dallman MJ
    Ann N Y Acad Sci; 1991 Dec; 636():295-305. PubMed ID: 1793217
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppressive therapy of autoimmune diseases.
    Bach JF
    Trends Pharmacol Sci; 1993 May; 14(5):213-6. PubMed ID: 8212318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of autoimmune disease with T cell subset specific antibodies.
    Sriram S; Ranges GE
    Concepts Immunopathol; 1987; 4():275-86. PubMed ID: 3297338
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model.
    Seydel K; Shizuru J; Grossman D; Wu A; Alters S; Fathman CG
    Diabetes; 1991 Nov; 40(11):1430-4. PubMed ID: 1834499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.